Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia

Saved in:
Bibliographic Details
Published in:Annals of hematology 2022-11, Vol.101 (11), p.2563-2564
Main Authors: Santaliestra, Marta, Ferrer-Marín, Francisca, Alvarez-Larrán, Alberto
Format: Article
Language:English
Subjects:
Hematology
Hemorrhage - chemically induced
Humans
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Platelet Aggregation Inhibitors - adverse effects
Quinazolines
Thrombocythemia, Essential - complications
Thrombocythemia, Essential - drug therapy
Thrombosis - etiology
Thrombosis - prevention & control
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-022-04956-y